Search Results
Sep 09, 2026, 16:30 ET JAAD Publication Shows Improved Performance of DecisionDx®-SCC
40-gene expression profile (i40-GEP) which provides prognostic and adjuvant radiation benefit for high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol. Published online August 24, 2026. Accessed August 25, 2026.
More news about: Castle Biosciences, Inc.
Aug 24, 2026, 07:00 ET Vanda Pharmaceuticals Granted Orphan Designation for Imsidolimab for the Treatment of Generalized Pustular Psoriasis by the European Commission
et al., "Treatments and outcomes of generalized pustular psoriasis: A cohort of 1516 patients in a nationwide inpatient database in Japan," J. Am. Acad. Dermatol., vol. 86, no. 6, pp. 1266–1274, Jun. 2022, doi: 10.1016/j.jaad.2021.06.008.About imsidolimabImsidolimab is a fully
More news about: Vanda Pharmaceuticals Inc.
Aug 20, 2026, 13:49 ET Vascarta Outlines Proposed Mechanistic Link Between VAS-101's (Vasceptor®) Vascular and Red Blood Cell Effects in Sickle Cell Disease
Cheng X, Kaur H, et al. Phenotypic screening of the ReFRAME drug repurposing library to discover new drugs for treating sickle cell disease. Proc Natl Acad Sci U S A. 2022;119(40):e2210779119.
More news about: Vascarta Inc.
Aug 11, 2026, 07:50 ET SLENYTO® (melatonin extended-release tablets) is now available in Canada as a prescription treatment for insomnia in children and adolescents with autism spectrum disorder (ASD) and/or Smith-Magenis syndrome (SMS).
Frydman-Marom A, Findling RL. Efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2017;56(11):948-957.e4. doi:10.1016/j.jaac.2017.09.414Tafolla M, Singer H, Lord C. Autism spectrum disorder across
More news about: Kye Pharmaceuticals Inc.
Aug 03, 2026, 15:00 ET Yale-Trained Plastic Surgeon Launches "Invisible Principles of Plastic Surgery" Educational Program
York: Metropolitan Books; 2002.Moulton CAE, Regehr G, Mylopoulos M, MacRae HM. Slowing down when you should: a new model of expert judgment. Acad Med. 2007;82(10 Suppl):S109-S116.Kahneman D, Klein G. Conditions for intuitive expertise: a failure to disagree. Am Psychol. 2009;64(6):515-526.Ericsson
More news about: LAWTON PLASTIC SURGERY
Aug 03, 2026, 09:00 ET BOTOX® (toxina botulínica A) recebe aprovação da Anvisa para uso no músculo platisma
of platysma prominence with onabotulinumtoxinA: Safety and efficacy results from a randomized, double-blinded, placebo-controlled phase 3 trial. J Am Acad Dermatol. 2025 Feb;92(2):285-291.Trindade de Almeida A, De Boulle K, Lorenc ZP, Carruthers J, Braz A, Bertossi D, Dimitrijevic E, Shimoga S,
More news about: Allergan
Jul 29, 2026, 03:00 ET AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
2026.Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. 2010;62(2):177-188, quiz 189-190. doi:10.1016/j.jaad.2009.10.032Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP.
More news about: AbbVie
Jul 29, 2026, 03:00 ET AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo
Vitiligo. Lancet. 2015;386(9988):74-84. doi:10.1016/S0140-6736(14)60763-7Speeckaert R, van Geel N. Distribution patterns in generalized vitiligo. J Eur Acad Dermatol Venereol. 2014;28(6):755-762. doi:10.1111/jdv.12171Taneja N, Sreenivas V, Sahni K, Gupta V, Ramam M. Disease stability in segmental
More news about: AbbVie
Jul 16, 2026, 16:30 ET Vanda Pharmaceuticals Announces EMA Positive Opinion for Orphan Drug Designation of Imsidolimab for Generalized Pustular Psoriasis - A Milestone Recognition of GPP as a Distinct Rare Disease in Europe
et al., "Treatments and outcomes of generalized pustular psoriasis: A cohort of 1516 patients in a nationwide inpatient database in Japan," J. Am. Acad. Dermatol., vol. 86, no. 6, pp. 1266–1274, Jun. 2022, doi: 10.1016/j.jaad.2021.06.008.About Vanda Pharmaceuticals Inc.Vanda
More news about: Vanda Pharmaceuticals Inc.
Jul 14, 2026, 16:30 ET Castle Biosciences Announces New York State Department of Health Approval of its AdvanceAD-Tx™ Test
expression profile test guides systemic therapy selection to improve outcomes for patients with atopic dermatitis: results from a prospective trial. J Am Acad Dermatol. 2026. doi:10.1016/j.jaad.2026.02.034Investor Contact:Camilla Zuckero
More news about: Castle Biosciences, Inc.
Jun 29, 2026, 03:10 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
ABVRRTI81456.Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: Part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. 2010;62(2):177-188, quiz 189-190.Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis
More news about: AbbVie
Jun 29, 2026, 03:10 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
ABVRRTI81456.Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: Part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. 2010;62(2):177-188, quiz 189-190.Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis
More news about: AbbVie
Jun 29, 2026, 03:00 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo
diagnosis and management of vitiligo: position statement from the International Vitiligo Task Force part 1: towards a new management algorithm. J Eur Acad Dermatol Venereol. 2023;37(11):2173-2184. doi:10.1111/jdv.19451Seneschal J, Boniface K. Vitiligo: Current therapies and future treatments.
More news about: AbbVie
Jun 29, 2026, 03:00 ET AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo
diagnosis and management of vitiligo: position statement from the International Vitiligo Task Force part 1: towards a new management algorithm. J Eur Acad Dermatol Venereol. 2023;37(11):2173-2184. doi:10.1111/jdv.19451Seneschal J, Boniface K. Vitiligo: Current therapies and future treatments.
More news about: AbbVie
Jun 08, 2026, 08:30 ET Kye Pharmaceuticals Announces the Availability of Dyanavel® XR Tablets Across Canada for the Treatment of ADHD
https://www.caddra.ca/wp-content/uploads/CADDRA_ADHD-Medication-Chart_May2026-EN-FR.pdf (Accessed July 2025)Duncan M: J Am Acad Child Adolesc Psychiatry. 1997 Oct;36(10 Suppl):85S-121S.
More news about: Kye Pharmaceuticals Inc.
May 27, 2026, 07:00 ET Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized Pustular Psoriasis
et al., "Treatments and outcomes of generalized pustular psoriasis: A cohort of 1516 patients in a nationwide inpatient database in Japan," J. Am. Acad. Dermatol., vol. 86, no. 6, pp. 1266–1274, Jun. 2022, doi: 10.1016/j.jaad.2021.06.008.About Vanda Pharmaceuticals Inc.Vanda
More news about: Vanda Pharmaceuticals Inc.
May 19, 2026, 15:14 ET BIMZELX® (bimekizumab-bkzx) demonstrates superior efficacy over SKYRIZI® (risankizumab-rzaa) in psoriatic arthritis: BE BOLD Week 16 data
et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol. 2013;69(5):729-735. doi: 10.1016/j.jaad.2013.07.023.Mease PJ, Armstrong AW. Managing patients with psoriatic disease: the diagnosis
More news about: UCB
May 06, 2026, 07:00 ET (E,E)-bisantrene Discovered to Function via Silencing of c-MYC Expression
L. H. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc. Natl. Acad. Sci. 99, 11593–11598 (2002).
More news about: Racura Oncology
Apr 28, 2026, 08:00 ET AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia Areata
Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: Part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. 2010;62(2):177-188, quiz 189-190. Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis
More news about: AbbVie
Apr 22, 2026, 02:46 ET NEW TELE-DENTISTRY PROGRAMME SUPPORTS EARLY INTERVENTION FOR CHILDREN AT RISK OF CARIES
S. Health practices, behaviours and quality of life of low-income preschoolers: A community-based cross-sectional comparison study in Singapore. Ann Acad Med Singap. 2024 Mar 27;53(3):142-151. doi: 10.47102/annals-acadmedsg.2023168. PMID: 38920242.
More news about: National University Health System (NUHS)
Mar 31, 2026, 11:15 ET DeuteRx Celebrates Women's History Month with Over a Decade of Pioneering Leadership in Drug Discovery
Proc Natl Acad Sci USA, 2015, 112, E1471).2018for Metabolic Disorders:
More news about: DeuteRx LLC
Mar 27, 2026, 10:00 ET AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting
Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, Gelfand JM. Psoriasis and comorbid diseases: Epidemiology. J Am Acad Dermatol. 2017 Mar;76(3):377-390. doi: 10.1016/j.jaad.2016.07.064. PMID: 28212759; PMCID: PMC5731650.Song EJ, Ehst B, Glick B, Lewitt
More news about: AbbVie
Mar 27, 2026, 09:00 ET Lilly's EBGLYSS (lebrikizumab-lbkz) delivered up to four years of durable disease control for patients with moderate-to-severe atopic dermatitis
moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE). J Am Acad Dermatol. 2018;78(5):863-871.e11. doi:10.1016/j.jaad.2018.01.0173 Okragly A, et al. Binding, Neutralization and Internalization
More news about: Eli Lilly and Company
Mar 25, 2026, 09:00 ET Merlin CP-GEP™ Demonstrates Superior Predictive Accuracy for Sentinel Lymph Node Metastasis in Early-Stage Melanoma
2024(6) Landow S.M. et al. Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013. J Am Acad Dermatol. 2017; 76: 258-263Media ContactICR HealthcareAlexis Feinberg+1 203-939-2225
More news about: SkylineDx
Mar 23, 2026, 14:26 ET Galderma reúne profissionais injetores para apresentar as últimas tendências em estética injetável
2013;39(6):915-922. 11. Morgan P, et al. Poster presented at IMCAS World Congress, 26-28 January 2023, Paris, France. 12. Narins RS, et al. J Am Acad Dermatol. 2010 Mar;62(3):448-62. 13. Data on File. 14. Di Gregorio C et al. Clin Cosmet Investig Dermatol. 2022 Apr
More news about: Galderma